MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.8478
+0.0325 (3.99%)
At close: Apr 17, 2026, 4:00 PM EDT
0.8203
-0.0275 (-3.24%)
After-hours: Apr 17, 2026, 7:57 PM EDT
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $90.6 million as of April 17, 2026. Its market cap has decreased by -69.12% in one year.
Market Cap
90.60M
Enterprise Value
5.50M
1-Year Change
-69.12%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $90.60M, a decrease of -81.69%. That is a compound annual growth rate of -28.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 90.60M | -45.21% |
| Dec 31, 2025 | 165.34M | -62.39% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
| Mar 10, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapid Micro Biosystems | 103.43M |
| Neuronetics | 97.41M |
| Sera Prognostics | 91.99M |
| Outset Medical | 80.57M |
| QT Imaging Holdings | 78.64M |
| Sensus Healthcare | 73.09M |
| Picard Medical | 71.90M |
| LENSAR | 70.15M |